AS a medical law and health policy researcher and having begun my pharmaceutical career managing HIV therapies before later representing Gilead Sciences’ antiviral portfolio in Malaysia, I have witnessed the disease evolving from what was once regarded as a terminal illness into a chronic, highly manageable condition.
Today, individuals receiving effective antiretroviral therapy can achieve sustained viral suppression, enjoy near-normal life expectancy and, under the globally recognised principle of Undetectable = Untransmittable (U=U), do not sexually transmit the virus when their viral load remains undetectable.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
